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Introduction 
Non-immune hydrops fetalis (NIFH) is associated with significant perinatal mortality (Nmton et al. 
2015). Management is dependent upon underlying aetiology with improved prognosis in treatable 
causes (Norton et al. 2015). Prenatal investigation is offered to identify chromosomal anomalies and 
fetal infection (Notion et al2015). A case ofNIFH with features of fetal anaemia caused by human 
parvovilus B19 (HPV19) infection in a fetus with Trisomy 21 .is .described with management of the 
pregnancy. 
Case Report 
A 25 year-old, multiparous woman was referred at 13 weeks and 6 days of gestation with an en-
larged nuchal translucency (4.8 millimetres). First trimester anatomy scan demonstrated no anomaly 
and prenatal chromosomal testing w~s declined. A fetal echocardiography at 20 weeks was normal. 
At 24 weeks NIFH w~s diag~osed with echogenic bowel, ven,triculomegaly (ventricular height of 
atrium measuring 10 millimetres) and cardiomegaly. The middle cerebral artery (MCA) .peak sys-
tolic velocimetry (PSV) was elevated at 49-50 centimetres/second ( cm/s) (more than 1.5 ·multiples 
of median (MoM)) and there was a high clinical suspicion of fetal anaemia. Intrauterine transfusion 
(IUT) was perfmmed by intrithepatic vein puncture with fetal blood sampling de~onstrating a hae-
moglobin of 5.5 gram/decilitre (g/dL). Uneventful IUT with pack cells to a haemoglobin 10g/dL 
was perfmmed. 
Quantitative fluorescence poly-merase chain reaction (QF-PCR)/chromosomal microanay testing, · 
and screening for cytomegalovirus, HPV19 and toxoplasmosis were performed. Maternal serology 
noted HPV19 positive for immunoglobulin M (IgM) antibodies. Fetal karyotype demonstrated Tri-
' 
somy 21 on QF-PCR (confi1med on full karyotyping) . The fetal blood film showed no evidence of 
transient abnormal myelopoiesis (TAM). A multidisciplinary team discussion concluded that fetal 
anaemia in this case was secondary to HPV19 infection rather than TAM and resolution of the 
anaemia was based on high reticulocyte count (more than 15%). MCA PSV was normal during sub-
sequent weekly follow up. Fetal deoxyribonucleic acid (DNA) was stored for GATAJ. mutational 
analysis. 
Discussion 
Fetal anaemia from HPV19 infection is a common causes ofNIFH (Bascietto et al. 2018). Sponta-
· neous resolution is low (Bascietto et al. 2018) and IUT is a well-established treatment (Lindenburg 
et al. 2013) evi~enced by raised MCA PSV (Moise. 2008). Clinical resolution of anaemia after the 
first IUT in this case excluded the need for furthe1: prenatal transfusions. 
Trisomy 21 is associated with TAM in up to 30% of cases·. TAM is diagnosed by increased blast 
. 
cells in neonates with Trisomy 21 and GATAJ mutation, although there is no internationally defined 
blast threshold to diagnose TAM. This transient leukaemia may be associated with childhood mye-
loid leukaemia of·Down syndrome (ML-DS) (Zipursky et al. 2003). For TAM to transfmm into 
I 
ML-DS, a three-step model is required in fetal Trisomy 21, with a GAT AI mutation and at least one 
additional oncogenic mutation occurring before the age of 5 years ha.s been proposed (Bhatnagar et 
al. 2016). 
Prenatal TAM presents most commonly in third trimester, with at least 2 ultrasound features (hepa-
tomegaly +/- splenomegaly, hydrops fetalis, pericardia! effusion, abenant liquor volume, cardiac 
abnmmalities, ascites, pleural effusion and peripheral oedema) seen in 71.8% of cases (Tamblyn et 
al. 2015). The presence ofNIFH associated with hepatomegaly in TAM has a very poor prognosis 
(92% mortality rate) (Tamblyn et al. 2015). 
This is an interesting case study of NIFH with Trisomy 21 which demonstrates a logical triage of 
aetiology with multidisciplinary management of a complex case. Rapid investigation of the fetal 
anaemia was attributed to HPV19 infection, excluding TAM, based on the absence of peripheral 
blood blast cells. Treatment of the life-threatening fetal anaemia by IUT has successfully reversed 
the hydrops caused by underlying HPV 19 infection. 
Conclusion 
The diagnosis and management of hydrops fetalis with Trisomy 21 is complex and although TAM 
is a possible cause, it ~s impmtant not to miss the more common diagnosis of HP,V19 infection 
which is treatable with IUT. 
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